Angina pectoris is most usefully explained by transient inadequacy of the myocardial oxygen supply relative to demand. It is a clinical syndrome, rather than the name of one visible anatomical lesion. The characteristic constricting chest discomfort may radiate to the arm, neck or jaw and be provoked by effort; the question concerns its causes, not a claim that every chest pain is angina pectoris.[ref]
Angina Causes and Risk Factors by NHLBI. What causes angina; coronary disease, microvascular disease and spasm
The common structural basis is coronary atherosclerosis. Narrowing limits the increase of coronary blood flow that should accompany exercise. An affected heart may receive sufficient oxygen at rest and insufficient oxygen when its rate, force of contraction and wall stress rise. Plaque disruption with thrombosis can abruptly worsen supply; persistent severe ischemia can then cause myocardial infarction. Pain from transient ischemia does not by itself prove myocardial necrosis.
Other mechanisms include coronary artery spasm, impaired regulation of small coronary vessels, or increased demand in left ventricular hypertrophy, severe aortic stenosis, or tachycardia. Reduced delivery through severe anaemia, low arterial oxygen or low perfusion pressure may provoke symptoms even without a new obstructing plaque. Structural narrowing, vasomotor change, blood oxygen-carrying capacity and cardiac work therefore have to be considered together.[ref]
Recent-onset Chest Pain of Suspected Cardiac Origin by NICE. Recommendations 1.3.7 and factors intensifying ischaemia: anaemia, spasm, tachycardia and ventricular hypertrophy
For an 1865 interpretation, coronary “ossification” or degeneration, diseased cardiac or aortic structures and neural or spasmodic explanations belonged to the historical discussion. These did not establish a single universal cause. A report published in January 1865 described a pathological case associated angina pectoris with diseased coronary arteries, but isolated cases cannot demonstrate that a particular valve or vessel lesion is necessary in every patient.[ref]
Half-Yearly Report on Pathology and Principles and Practice of Medicine (1865). pp. 255–256, section XII: coronary openings narrowed and disease around the cardiac plexus
The modern supply-and-demand account explains why severe symptoms can coexist with relatively inconspicuous large coronary arteries, and why substantial coronary disease need not cause pain at every moment.A pathological investigation inspects the coronary origins and course, their lumen and wall, the myocardium, the aortic valve and ventricular thickness. Clinical investigation adds evidence of reversible myocardial ischaemia and distinguishes it from infarction or non-cardiac pain. Modern electrocardiography and appropriate imaging address functions that a nineteenth-century post-mortem inspection alone could not measure. A normal-looking vessel on gross inspection cannot exclude coronary microvascular disease or a transient coronary artery spasm.
Modern hypertrophy means enlargement of individual biological cells; hyperplasia means an increase in their number. Both can enlarge an organ, and both can occur together. The historical question requires care because nineteenth-century authors sometimes included “numerical hypertrophy” within the broader discussion of growth. Rudolf Virchow's 1860 English edition explicitly distinguishes enlargement of existing elements from multiplication of elements, using simple and numerical hypertrophy for these different processes.[ref]
Cellular Pathology by Rudolf Virchow (1860). Lecture III, pp. 93–95, Hypertrophy and Hyperplasy and Degenerative New Formations
At the minute structural level, true hypertrophy entails increased cellular substance and, in a contractile biological cell, more contractile apparatus. Enlarged cell nuclei can accompany it, but a large cell nucleus alone does not prove a proportional increase in functional tissue. Increased cell number belongs to hyperplasia. Apparent organ enlargement from oedema, fatty infiltration, amyloid or a tumour must be distinguished from a coordinated increase of the organ's working tissue.[ref]
Cellular Pathology in Pathology: The Big Picture. Hypertrophy and Hyperplasia; morphological distinction and increased contractile protein in pressure-loaded myocardium
The clearest early-to-late examples compare adaptation with the possible effects of continued overload:
- In the heart, sustained hypertension or aortic stenosis makes the left ventricle work against greater resistance. Initially its cardiomyocytes enlarge and the wall thickens, with enlarged cell nuclei and increased contractile proteins. With prolonged pathological stress there may be fibrosis, loss of cardiomyocytes, ventricular dilatation and heart failure. The late enlarged failing heart need not have a uniformly thick wall; hypertrophy and dilatation describe different structural changes.[ref]Stress Kinase Signaling in Cardiac Myocytes. Cardiac hypertrophy, physiological adaptation versus pathological hypertrophy and progression to heart failure
- In the urinary bladder, persistent outflow obstruction increases the work of the detrusor muscle. Enlargement of smooth muscle bundles thickens the wall and can produce bladder trabeculation. With prolonged obstruction, fibrosis, dilatation and incomplete emptying can coexist with the initial growth. This is a progression possible under sustained pathological load. Human studies describe early hypertrophy and subsequent compensation or decompensation; progression is not an inevitable fate of all enlarged smooth muscle.[ref]Progressive bladder remodeling due to bladder outlet obstruction. Results; Discussion, proposed three-stage model and its evidential limits
- In skeletal muscle, increased use enlarges existing fibres through additional contractile material. Later development of this physiological response produces larger, stronger fibres; it does not inherently require fatty degeneration. If an apparent muscular enlargement is mainly fat or connective tissue, that is pseudohypertrophy.
These illustrations compare different outcomes rather than proposing a universal stage in which every enlarged organ degenerates.[ref]
Hypertrophy and hyperplasia in Underwood's Pathology: a Clinical Approach. Adaptive responses to increased demand; physiological hypertrophy and hyperplasia
[ref]Cellular Pathology in Pathology: The Big Picture. Hypertrophy, physiological and pathological examples
A second set illustrates growth in organs whose biological cells can also divide. The pregnant uterus combines marked enlargement of smooth muscle biological cells with an increase in their number; after delivery it undergoes involution. An enlarged remaining kidney after loss of its partner exemplifies compensatory growth. In a modern rat experiment comparing neonatal, weanling and adult animals after removal of one kidney, the younger groups showed greater compensatory growth; that experimental comparison does not make an age-independent prediction for every human kidney.[ref]
Age-dependent characteristics of compensatory renal growth. Abstract, comparison of neonatal, weanling and young adult rats
Thus organ size alone cannot distinguish the cellular processes: compare cell dimensions, numbers and tissue composition by histology.[ref]Hypertrophy and hyperplasia in Underwood's Pathology: a Clinical Approach. Physiological hypertrophy and hyperplasia, uterine growth; compensatory growth